Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy

William J. Ledger, Richard L Sweet, John T. Headington

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

A prospective double-blind study was performed utilizing 3 Gm. of cephaloridine or placebo on the day of operation in premenopausal women undergoing vaginal hysterectomy. In approximately two years, 100 of 138 women eligible for the study elected to participate; 50 patients received placebo and 50 received active drug. The preoperative profile of the two groups of patients was similar. Postoperatively, there were statistically significant differences in the clinical courses of the two groups of patients. In those women receiving cephaloridine prophylaxis, fewer patients had postoperative morbidity (p < 0.025). This seemed directly related to the decreased incidence of postoperative pelvic infections in the antibiotic group (p < 0.005). The implications of these findings are discussed.

Original languageEnglish (US)
Pages (from-to)766-774
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume115
Issue number6
StatePublished - Mar 15 1973
Externally publishedYes

Fingerprint

Pelvic Infection
Cephaloridine
Vaginal Hysterectomy
Placebos
Double-Blind Method
Anti-Bacterial Agents
Morbidity
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. / Ledger, William J.; Sweet, Richard L; Headington, John T.

In: American Journal of Obstetrics and Gynecology, Vol. 115, No. 6, 15.03.1973, p. 766-774.

Research output: Contribution to journalArticle

@article{b4860c0360e2468383399cefd588a0a7,
title = "Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy",
abstract = "A prospective double-blind study was performed utilizing 3 Gm. of cephaloridine or placebo on the day of operation in premenopausal women undergoing vaginal hysterectomy. In approximately two years, 100 of 138 women eligible for the study elected to participate; 50 patients received placebo and 50 received active drug. The preoperative profile of the two groups of patients was similar. Postoperatively, there were statistically significant differences in the clinical courses of the two groups of patients. In those women receiving cephaloridine prophylaxis, fewer patients had postoperative morbidity (p < 0.025). This seemed directly related to the decreased incidence of postoperative pelvic infections in the antibiotic group (p < 0.005). The implications of these findings are discussed.",
author = "Ledger, {William J.} and Sweet, {Richard L} and Headington, {John T.}",
year = "1973",
month = "3",
day = "15",
language = "English (US)",
volume = "115",
pages = "766--774",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy

AU - Ledger, William J.

AU - Sweet, Richard L

AU - Headington, John T.

PY - 1973/3/15

Y1 - 1973/3/15

N2 - A prospective double-blind study was performed utilizing 3 Gm. of cephaloridine or placebo on the day of operation in premenopausal women undergoing vaginal hysterectomy. In approximately two years, 100 of 138 women eligible for the study elected to participate; 50 patients received placebo and 50 received active drug. The preoperative profile of the two groups of patients was similar. Postoperatively, there were statistically significant differences in the clinical courses of the two groups of patients. In those women receiving cephaloridine prophylaxis, fewer patients had postoperative morbidity (p < 0.025). This seemed directly related to the decreased incidence of postoperative pelvic infections in the antibiotic group (p < 0.005). The implications of these findings are discussed.

AB - A prospective double-blind study was performed utilizing 3 Gm. of cephaloridine or placebo on the day of operation in premenopausal women undergoing vaginal hysterectomy. In approximately two years, 100 of 138 women eligible for the study elected to participate; 50 patients received placebo and 50 received active drug. The preoperative profile of the two groups of patients was similar. Postoperatively, there were statistically significant differences in the clinical courses of the two groups of patients. In those women receiving cephaloridine prophylaxis, fewer patients had postoperative morbidity (p < 0.025). This seemed directly related to the decreased incidence of postoperative pelvic infections in the antibiotic group (p < 0.005). The implications of these findings are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0015924670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015924670&partnerID=8YFLogxK

M3 - Article

C2 - 4569662

AN - SCOPUS:0015924670

VL - 115

SP - 766

EP - 774

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -